中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2009年
11期
835-838
,共4页
蒋永剑%虞先浚%徐近%李骥%傅德良%倪泉兴
蔣永劍%虞先浚%徐近%李驥%傅德良%倪泉興
장영검%우선준%서근%리기%부덕량%예천흥
胰腺肿瘤%多药耐药%MDR1%MRP
胰腺腫瘤%多藥耐藥%MDR1%MRP
이선종류%다약내약%MDR1%MRP
Pancreatic neoplasms%Muhidrug resistance%MDR1%MRP
目的 构建胰腺癌多药耐药细胞株BxPC-3/ADM,通过动态监测诱导耐药过程,探讨其耐药的可能机制.方法 逐步增加阿霉素浓度对BxPC-3细胞进行诱导,在不同的阿霉素诱导浓度,MTT法检测细胞对多种化疗药物的耐药指数,RT-PCR和Western印迹法检测细胞MDR1和MRP mRNA和蛋白的表达.结果 成功构建多药耐药细胞株BxPC-3/ADM;在0.05 μg/ml至8 μg/ml阿霉素诱导浓度,细胞对5-Fu、MMC和Gem的耐药指数无明显增加;在16 μg/ml浓度3种化疗药物的耐药指数有较明显上升,同时伴有MDR1 mRNA表达的明显增加;至32 μg/ml 5-Fu和Gem的耐药指数未再有继续上升,而MMC的耐药指数则继续上升,同时MDR1 mRNA表达未再增加,而MRP mRNA表达则明显增加.Western印迹实验显示MDR1和MRP蛋白表达变化与mRNA表达变化趋势一致.结论 MDR1基因在诱导早期的耐药中起主导作用,在后期则和MRP基因协同发挥作用.
目的 構建胰腺癌多藥耐藥細胞株BxPC-3/ADM,通過動態鑑測誘導耐藥過程,探討其耐藥的可能機製.方法 逐步增加阿黴素濃度對BxPC-3細胞進行誘導,在不同的阿黴素誘導濃度,MTT法檢測細胞對多種化療藥物的耐藥指數,RT-PCR和Western印跡法檢測細胞MDR1和MRP mRNA和蛋白的錶達.結果 成功構建多藥耐藥細胞株BxPC-3/ADM;在0.05 μg/ml至8 μg/ml阿黴素誘導濃度,細胞對5-Fu、MMC和Gem的耐藥指數無明顯增加;在16 μg/ml濃度3種化療藥物的耐藥指數有較明顯上升,同時伴有MDR1 mRNA錶達的明顯增加;至32 μg/ml 5-Fu和Gem的耐藥指數未再有繼續上升,而MMC的耐藥指數則繼續上升,同時MDR1 mRNA錶達未再增加,而MRP mRNA錶達則明顯增加.Western印跡實驗顯示MDR1和MRP蛋白錶達變化與mRNA錶達變化趨勢一緻.結論 MDR1基因在誘導早期的耐藥中起主導作用,在後期則和MRP基因協同髮揮作用.
목적 구건이선암다약내약세포주BxPC-3/ADM,통과동태감측유도내약과정,탐토기내약적가능궤제.방법 축보증가아매소농도대BxPC-3세포진행유도,재불동적아매소유도농도,MTT법검측세포대다충화료약물적내약지수,RT-PCR화Western인적법검측세포MDR1화MRP mRNA화단백적표체.결과 성공구건다약내약세포주BxPC-3/ADM;재0.05 μg/ml지8 μg/ml아매소유도농도,세포대5-Fu、MMC화Gem적내약지수무명현증가;재16 μg/ml농도3충화료약물적내약지수유교명현상승,동시반유MDR1 mRNA표체적명현증가;지32 μg/ml 5-Fu화Gem적내약지수미재유계속상승,이MMC적내약지수칙계속상승,동시MDR1 mRNA표체미재증가,이MRP mRNA표체칙명현증가.Western인적실험현시MDR1화MRP단백표체변화여mRNA표체변화추세일치.결론 MDR1기인재유도조기적내약중기주도작용,재후기칙화MRP기인협동발휘작용.
Objective To construct muhidrug resistance cell line BxPC-3/ADM of pancreatic cancer and investigate its resistance mechanism through dynamically monitoring the inducing course. Methods BxPC-3 cell was induced by increasing the concentration of ADM gradually. At the different inducing concentrations of ADM, the resistance indexes to multiple chemotherapeutics were detected by MTT and the mRNA and protein expression of MDR1 and MRP were determined by RT-PCR and Western blot, respectively. Results Muhidrug resistant cell line BxPC-3/ADM was constructed suc-cessfully. When the inducing concentration of ADM was from 0.05 μg/ml to 8 μg/ml, the resistance indexes to 5-Fu, MMC and Gem did not significantly increase. When the inducing concentration of ADM was 16 μg/ml, the resistance indexes to three chemotherapeutics increased significantly and the mRNA expression of MDR1 obviously rose simultaneously. When the inducing concentration of ADM was 32 μg/ml, the resistance indexes to 5-Fu and Gem did not increase continually, whereas the re-sistance index to MMC increased continually. Meanwhile, the mRNA expression of MDR1 did not keep on rising, whereas the mRNA expression of MRP obviously increased. Western blot showed that the change of MDR1 and MRP protein expression was consistent with the change of mRNA expres-sion. Conclusion During the inducing course, MDR1 has its main contribution at the early stage, whereas MDR1 and MRP have co-contributing action at the late stage.